Clinical Trials Logo

Myopia clinical trials

View clinical trials related to Myopia.

Filter by:

NCT ID: NCT05367154 Completed - Myopia Clinical Trials

Factor Analysis of Unintended Initial Dissection of the Posterior Plane

Start date: April 1, 2021
Phase:
Study type: Observational

To explore the potential factors for unintended initial dissection of the posterior plane in a large sample retrospective analysis and surgeons of different levels.

NCT ID: NCT05365373 Completed - Myopia Clinical Trials

The Effect of Treatment Zone Decentration on Axial Length Elongation After Orthokeratology

Start date: January 1, 2018
Phase:
Study type: Observational

Orthokeratology lens is an effective method for myopia control. This study analyzed the effects of treatment zone decentration on axial length elongation in adolescents with orthokeratology lens.

NCT ID: NCT05357326 Recruiting - Myopia Clinical Trials

Myopia Intervention in Children and Adolescents and Establishment of a Precise Intervention Model

Start date: July 1, 2021
Phase: Phase 4
Study type: Interventional

Investigators are going to conduct a multi-centered randomized clinical trial that myopic children are randomly allocated into three groups: 0.01% atropine, 0.04% atropine and orthokeratology in order to evaluate the efficacy and side effects of different intervention methods and establish a risk factor model to predict the efficacy of myopia intervention, and to provide precise intervention plans and clinical decisions for the control of myopia.

NCT ID: NCT05352854 Not yet recruiting - Glaucoma Clinical Trials

Morphological Changes of Ciliary Body and Trabecular Meshwork

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

Glaucoma is the leading cause of irreversible blindness worldwide. Although the pathogenesis remains unclear, pathologic increase in intraocular pressure (IOP) due to blocked aqueous outflow through the trabecular-Schlemm canal is known to be an important risk factor, and reduction of IOP is the only clinically validated way to retard the progression of OAG. Ciliary muscle plays a central role in the trabecular meshwork-Schlemm canal outflow pathway. Clinical evidence suggests that ciliary muscle contraction stimulated by cholinergic receptor agonist and retraction of ciliary body position after cataract surgery can dilate the lumen of Schlemm canal and reduce IOP. Currently, Ultrasound biomicroscopy (UBM) can obtain two-dimensional images of the anterior segment using high-frequency Ultrasound transducers in medical imaging studies of the ciliary body - trabecular meshwork -Schlemm canal complex. UBM has better tissue penetration than Optical coherence tomography (OCT) and can image the ciliary body better, but it has a lower resolution (30um to 50um) and is poor at imaging tiny tissues such as trabecular meshwork and Schlemm canal. The latest swept-source OCT (SS-OCT) has faster image capture rate (1000000 A scans/SEC), stronger penetration and higher resolution (8um axial resolution and 20um transverse resolution). The structure and morphology of ciliary body-trabecular meshwork-Schlemm canal complex can be clearly photographed. The investigators intend to use CASIA2 to image the ciliary body-trabecular meshwork-Schlemm canal complex before and after administration of pilocarpine in healthy individuals and patients with glaucoma to assess the effect of pilocarpine on the anatomy of the ciliary body-trabecular meshwork-Schlemm canal complex.

NCT ID: NCT05348369 Completed - Myopia Clinical Trials

The Relationship of Relative Corneal Refractive Power Shift and Axial Length in Adolescents With Orthokeratology Lens

Start date: January 1, 2018
Phase:
Study type: Observational

Orthokeratology lens is an effective method for myopia control. This study analyzed the relationship between the relative corneal refractive power shift and change of axial length in adolescents with orthokeratology lens.

NCT ID: NCT05340699 Active, not recruiting - Myopia Clinical Trials

Safety and Efficacy of Defocus Distributed Multi-point Lens in Myopia Control

Start date: May 1, 2022
Phase: N/A
Study type: Interventional

Evaluate the safety and effectiveness of experimental group by comparing with the control group

NCT ID: NCT05336799 Recruiting - Myopia Clinical Trials

Prevalence and Environmental Factors for Myopia Among Chinese School-aged Children and Adolescent in Tianjin

Start date: March 1, 2021
Phase:
Study type: Observational

The high prevalence of myopia has become a global public health problem. The study amied to investigate the prevalence and progression of myopia associated with social environmental factors in Tianjin, a Chinese megacity in north China.

NCT ID: NCT05333965 Completed - Myopia Clinical Trials

To Evaluate The Performance Of Two Monthly Replacement Silicone Hydrogel Contact Lenses After 1-month Of Wear

Start date: April 27, 2022
Phase: N/A
Study type: Interventional

To evaluate the performance of two monthly replacement silicone hydrogel contact lenses in habitual FRP CL wearers when worn for 1-month.

NCT ID: NCT05331378 Active, not recruiting - Myopia Clinical Trials

Clinical Evaluation of a Myopia Control Lens in Slowing Myopia Progression

Start date: April 25, 2022
Phase: N/A
Study type: Interventional

This is a monocenter, randomized, controlled, parallel-group, double-masked clinical trial to evaluate the effectiveness of test lens in slowing myopia progression with respect to axial length elongation at baseline compared to a single vision spectacle lens (control). A total of 80 children will be recruited where 40 subjects will be allocated either to wear test lenses (group 1) or control lenses (group 2) for 1 year through randomization.

NCT ID: NCT05320042 Completed - Myopia Clinical Trials

1-Week Dispensing Evaluation of Kalifilcon A Toric Contact Lenses Compared to Ultra for Astigmatism

Start date: February 14, 2022
Phase: N/A
Study type: Interventional

Experienced soft contact lens wearing subjects will be enrolled in this 1-week, confirmatory, randomized, bilateral, 2-way crossover, double masked (subject and investigator), repeated measures, dispensing study. All subjects will be seen for a Screening/Baseline Visit at which informed consent will be obtained and eligibility will be assessed.